Cutaneous lupus erythematosus (CLE) is a rare autoimmune disease with a heterogeneous spectrum of clinical manifestations on the skin. Prof. Dr. med. Luca Borradori, Chief Physician and Clinic Director of Dermatology at Inselspital Bern, gave an up-to-date overview of the diagnostic clarifications to be carried out in the event of a clinical suspicion of CLE and the treatment options available. With adequate disease management, many CLE patients can maintain a good quality of life.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Peristomal skin health
Focus on preventive care options
- Disease-modifying therapies for ATTR-CM
TTR stabilizers, gene silencing and gene scissors: where do we stand?
- Proteins in wound healing
Do special amino acids lead to success?
- HER2+ early breast cancer
DESTINY-Breast11 – neoadjuvant T-DXd without anthracyclines
- Lavender aromatherapy
Take away the fear of the dentist
- Digital dermatology: innovative project examples
AI and eHealth tools in HS care
- Mantle cell lymphoma
Recurrence after BTK inhibition – prognostic factors and treatment options
- Dementia risk with type 2 diabetes